NCT07154134 Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome
| NCT ID | NCT07154134 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Endocan |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-10 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-07-10 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.
Eligibility Criteria
Inclusion Criteria: * Prematurity. * Gestational age between 28 and 36 weeks. * Suffering from respiratory distress syndrome. Exclusion Criteria: * Intrauterine growth restriction (IUGR). * Hypoxic ischemic encephalopathy. * Multiple congenital anomalies. * Chromosomal abnormalities. * Preterm less than 28 weeks. * Neonates with a maternal history of chorioamnionitis (early sepsis). * Infant of diabetic mother. * Prelabor rupture of membranes (PROM)\> 2 hours.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07154134 clinical trial?
This trial is open to participants of all sexes, aged 28 Weeks or older, up to 36 Weeks, studying Endocan. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07154134 currently recruiting?
Yes, NCT07154134 is actively recruiting participants. Contact the research team at asmaa.elmesery@med.tanta.edu.eg for enrollment information.
Where is the NCT07154134 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07154134 clinical trial?
NCT07154134 is sponsored by Tanta University. The trial plans to enroll 40 participants.